Acadian Asset Management’s Apyx Medical APYX Stock Holding History

Acadian Asset Management’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$327K	Buy	74,555 +23,145	+45%	+$91.8K	﹤0.01%	1543
2026 Q1	$185K	Buy	51,410 +12,627	+33%	+$47.2K	﹤0.01%	1612
2025 Q4	$131K	Buy	+38,783	New	+$135K	﹤0.01%	1616
2023 Q2	–	Sell	-4,458	Closed	-$12K	–	1717
2023 Q1	$12K	Sell	4,458 -225,916	-98%	-$660K	﹤0.01%	1680
2022 Q4	$537K	Buy	+230,374	New	+$703K	﹤0.01%	1014
2021 Q4	–	Sell	-4,508	Closed	-$62K	–	1661
2021 Q3	$62K	Buy	+4,508	New	+$47.4K	﹤0.01%	1526
2019 Q2	–	Sell	-66,069	Closed	-$417K	–	1770
2019 Q1	$417K	Sell	66,069 -27,494	-29%	-$213K	﹤0.01%	1146
2018 Q4	$607K	Buy	93,563 +61,705	+194%	+$374K	﹤0.01%	858
2018 Q3	$226K	Buy	+31,858	New	+$177K	﹤0.01%	1058
2018 Q2	–	Sell	-9,328	Closed	-$27K	–	1687
2018 Q1	$27K	Buy	+9,328	New	+$24K	﹤0.01%	1454

Other funds holding APYX

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management's APYX Position: Q2 2026 in Review

Acadian Asset Management increased its Apyx Medical (APYX) stake by 45% in Q2 2026, buying an estimated $91.8K and bringing the position to 74,555 shares worth $327K. The position accounts for ﹤0.01% of the portfolio, ranked #1543.

Acadian Asset Management first reported a position in APYX in Q1 2018 and has held it in 10 quarters since. The position peaked at $607K in Q4 2018. 67 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

Acadian Asset Management held 74,555 shares of Apyx Medical worth $327K as of Q2 2026.
Acadian Asset Management bought 23,145 Apyx Medical shares in Q2 2026, an estimated $91.8K.
Apyx Medical made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1543 holding.
Acadian Asset Management first reported a position in Apyx Medical in Q1 2018 and has held it in 10 quarters since.
Acadian Asset Management's Apyx Medical position peaked at $607K in Q4 2018.
67 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.